Role of positron emission tomography/computed tomography in Dementia

Sidney R. Hinds, Derek J. Stocker, Yong Bradley

Research output: Contribution to journalReview article

2 Citations (Scopus)

Abstract

This article provides a clinically based review of positron emission tomography (PET) imaging for dementia. Significant advances in nuclear medicine and molecular imaging techniques have improved the understanding of the genetic and molecular processes that define neurodegenerative dementia diseases. Metabolic imaging remains constant in its ability to document neuronal loss and lost function. Amyloid-β radiotracers are useful in documenting amyloid deposition, differentiating origins of dementia and possibly predicting disease progression. These radiotracers may be useful in diagnosis-specific treatment. PET radiotracers have increased sensitivity and specificity to complement clinical presentation and other adjunct testing in the evaluation of dementia.

Original languageEnglish (US)
Pages (from-to)927-934
Number of pages8
JournalRadiologic Clinics of North America
Volume51
Issue number5
DOIs
StatePublished - Sep 1 2013

Fingerprint

Dementia
Amyloid
Positron-Emission Tomography
Genetic Phenomena
Molecular Imaging
Aptitude
Nuclear Medicine
Neurodegenerative Diseases
Disease Progression
Sensitivity and Specificity
Positron Emission Tomography Computed Tomography

All Science Journal Classification (ASJC) codes

  • Radiology Nuclear Medicine and imaging

Cite this

Role of positron emission tomography/computed tomography in Dementia. / Hinds, Sidney R.; Stocker, Derek J.; Bradley, Yong.

In: Radiologic Clinics of North America, Vol. 51, No. 5, 01.09.2013, p. 927-934.

Research output: Contribution to journalReview article

Hinds, Sidney R. ; Stocker, Derek J. ; Bradley, Yong. / Role of positron emission tomography/computed tomography in Dementia. In: Radiologic Clinics of North America. 2013 ; Vol. 51, No. 5. pp. 927-934.
@article{5d5de2fcdf6b4bd6aa38beeab7a0d10f,
title = "Role of positron emission tomography/computed tomography in Dementia",
abstract = "This article provides a clinically based review of positron emission tomography (PET) imaging for dementia. Significant advances in nuclear medicine and molecular imaging techniques have improved the understanding of the genetic and molecular processes that define neurodegenerative dementia diseases. Metabolic imaging remains constant in its ability to document neuronal loss and lost function. Amyloid-β radiotracers are useful in documenting amyloid deposition, differentiating origins of dementia and possibly predicting disease progression. These radiotracers may be useful in diagnosis-specific treatment. PET radiotracers have increased sensitivity and specificity to complement clinical presentation and other adjunct testing in the evaluation of dementia.",
author = "Hinds, {Sidney R.} and Stocker, {Derek J.} and Yong Bradley",
year = "2013",
month = "9",
day = "1",
doi = "10.1016/j.rcl.2013.06.002",
language = "English (US)",
volume = "51",
pages = "927--934",
journal = "Radiologic Clinics of North America",
issn = "0033-8389",
publisher = "W.B. Saunders Ltd",
number = "5",

}

TY - JOUR

T1 - Role of positron emission tomography/computed tomography in Dementia

AU - Hinds, Sidney R.

AU - Stocker, Derek J.

AU - Bradley, Yong

PY - 2013/9/1

Y1 - 2013/9/1

N2 - This article provides a clinically based review of positron emission tomography (PET) imaging for dementia. Significant advances in nuclear medicine and molecular imaging techniques have improved the understanding of the genetic and molecular processes that define neurodegenerative dementia diseases. Metabolic imaging remains constant in its ability to document neuronal loss and lost function. Amyloid-β radiotracers are useful in documenting amyloid deposition, differentiating origins of dementia and possibly predicting disease progression. These radiotracers may be useful in diagnosis-specific treatment. PET radiotracers have increased sensitivity and specificity to complement clinical presentation and other adjunct testing in the evaluation of dementia.

AB - This article provides a clinically based review of positron emission tomography (PET) imaging for dementia. Significant advances in nuclear medicine and molecular imaging techniques have improved the understanding of the genetic and molecular processes that define neurodegenerative dementia diseases. Metabolic imaging remains constant in its ability to document neuronal loss and lost function. Amyloid-β radiotracers are useful in documenting amyloid deposition, differentiating origins of dementia and possibly predicting disease progression. These radiotracers may be useful in diagnosis-specific treatment. PET radiotracers have increased sensitivity and specificity to complement clinical presentation and other adjunct testing in the evaluation of dementia.

UR - http://www.scopus.com/inward/record.url?scp=84883414869&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84883414869&partnerID=8YFLogxK

U2 - 10.1016/j.rcl.2013.06.002

DO - 10.1016/j.rcl.2013.06.002

M3 - Review article

VL - 51

SP - 927

EP - 934

JO - Radiologic Clinics of North America

JF - Radiologic Clinics of North America

SN - 0033-8389

IS - 5

ER -